SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.
Saved in:
| Title: | SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy. |
|---|---|
| Authors: | Millan AJ; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Allain V; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, United States.; INSERM UMR976, Hôpital Saint-Louis, Université Paris Cité, Paris, France., Nayak I; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States., Libang JB; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Quijada-Madrid LM; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Arakawa-Hoyt JS; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Ureno G; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Rothrock AG; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, United States., Shemesh A; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Aguilar OA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Eyquem J; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States.; INSERM UMR976, Hôpital Saint-Louis, Université Paris Cité, Paris, France., Das J; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States.; Department of Pediatrics, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States.; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, OH, United States.; Pelotonia Institute for Immuno-Oncology, College of Medicine, The Ohio State University, Columbus, OH, United States., Lanier LL; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States. |
| Source: | Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2025 Mar 01; Vol. 214 (3), pp. 384-398. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
